跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA NORMON 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA NORMON 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA NORMON 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorios Normon S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 12, 2020
Approval ID
7e83a3bcf828f4ed
Company
Laboratorios Normon S.A.
Type
Standard
Approval Details
Approval Id
7e83a3bcf828f4ed
Drug Cima Aemps Name
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA NORMON 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85253
Holder Company Name
Laboratorios Normon S.A.
Marketing Company Name
Laboratorios Normon S.A.
Authorization Date
2020-07-12
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg/160 mg/12,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Normon S.A.
Active Ingredients
AMLODIPINO BESILATO
6,95 mg
VALSARTAN
160 mg
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 12, 2020
Approval ID
7e83a3bcf828f4ed
Type
Standard
Back to CIMA-AEMPS Approvals